{"id":"https://openalex.org/W2501746775","doi":"https://doi.org/10.1080/2162402x.2016.1211221","title":"Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity","display_name":"Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity","publication_year":2016,"publication_date":"2016-08-03","ids":{"openalex":"https://openalex.org/W2501746775","doi":"https://doi.org/10.1080/2162402x.2016.1211221","mag":"2501746775","pmid":"https://pubmed.ncbi.nlm.nih.gov/27757306","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5048777"},"language":"en","primary_location":{"id":"doi:10.1080/2162402x.2016.1211221","doi":"https://doi.org/10.1080/2162402x.2016.1211221","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2016.1211221","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1211221?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1211221?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083621673","display_name":"Leonid Dubrovsky","orcid":"https://orcid.org/0000-0003-2799-4765","observed_orcids":["https://orcid.org/0000-0003-2799-4765"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonid Dubrovsky","raw_affiliation_strings":["Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035010583","display_name":"Elliott Joseph Brea","orcid":"https://orcid.org/0000-0002-6283-0267","observed_orcids":["https://orcid.org/0000-0002-6283-0267"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elliott Joseph Brea","raw_affiliation_strings":["Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA","Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","Weill Cornell Medical College, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medical College, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103182824","display_name":"Dmitry Pankov","orcid":"https://orcid.org/0000-0002-2262-9294","observed_orcids":["https://orcid.org/0000-0002-2262-9294","https://orcid.org/0009-0000-5562-7925"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dmitry Pankov","raw_affiliation_strings":["Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Immunology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","Immunology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Immunology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Immunology Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109703682","display_name":"Emily R. Casey","orcid":"https://orcid.org/0009-0008-8381-6879","observed_orcids":["https://orcid.org/0009-0008-8381-6879"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Casey","raw_affiliation_strings":["Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062508226","display_name":"Tao Dao","orcid":"https://orcid.org/0000-0001-9937-6283","observed_orcids":["https://orcid.org/0000-0001-9937-6283"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tao Dao","raw_affiliation_strings":["Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100681942","display_name":"Liu C","orcid":"https://orcid.org/0000-0002-2219-1018","observed_orcids":["https://orcid.org/0000-0002-2219-1018"]},"institutions":[{"id":"https://openalex.org/I4210087205","display_name":"Eureka Therapeutics (United States)","ror":"https://ror.org/0056pgw95","country_code":"US","type":"company","lineage":["https://openalex.org/I4210087205"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheng Liu","raw_affiliation_strings":["Eureka Therapeutics, Emeryville, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eureka Therapeutics, Emeryville, CA, USA","institution_ids":["https://openalex.org/I4210087205"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006680533","display_name":"David A. Scheinberg","orcid":"https://orcid.org/0000-0002-4160-923X","observed_orcids":["https://orcid.org/0000-0002-4160-923X","https://orcid.org/0009-0009-0651-7389"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"David A. Scheinberg","raw_affiliation_strings":["Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA","Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","Weill Cornell Medical College, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Molecular Pharmacology Program, Sloan-Kettering Institute, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]},{"raw_affiliation_string":"Weill Cornell Medical College, New York, NY, USA","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5006680533"],"corresponding_institution_ids":["https://openalex.org/I1334819555","https://openalex.org/I4387153466"],"apc_list":{"value":2375,"currency":"GBP","value_usd":2913},"apc_paid":{"value":2375,"currency":"GBP","value_usd":2913},"fwci":0.3285,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.60759217,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"5","issue":"9","first_page":"e1211221","last_page":"e1211221"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.33250001072883606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.33250001072883606,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.2734000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.12540000677108765,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.746999979019165},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9559999704360962},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/leukemia-relapse","display_name":"leukemia relapse","score":0.7480000257492065},{"id":"https://openalex.org/keywords/wt1","display_name":"WT1","score":0.48399999737739563},{"id":"https://openalex.org/keywords/hla-a-0201","display_name":"HLA-A*0201","score":0.8899999856948853},{"id":"https://openalex.org/keywords/effector-to-target-ratio","display_name":"effector-to-target ratio","score":0.7170000076293945},{"id":"https://openalex.org/keywords/p27","display_name":"p27","score":0.9049999713897705},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.6859999895095825},{"id":"https://openalex.org/keywords/antigen-downregulation","display_name":"antigen downregulation","score":0.6320000290870667},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.8396717309951782},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.7195749282836914},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.5627012848854065},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5562800168991089},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.529668927192688},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5187699794769287},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4919531047344208},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.46713876724243164},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.44199052453041077},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3580676019191742},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3095705509185791},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1787431240081787},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1080/2162402x.2016.1211221","doi":"https://doi.org/10.1080/2162402x.2016.1211221","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2016.1211221","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1211221?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5048777","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5048777","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Text"},{"id":"pmid:27757306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27757306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoimmunology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/2162402x.2016.1211221","doi":"https://doi.org/10.1080/2162402x.2016.1211221","is_oa":true,"landing_page_url":"https://doi.org/10.1080/2162402x.2016.1211221","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1211221?needAccess=true&role=button","source":{"id":"https://openalex.org/S2497914550","display_name":"OncoImmunology","issn_l":"2162-4011","issn":["2162-4011","2162-402X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoImmunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1574533925","display_name":"Immunobiology of Allogeneic Hematopoietic Cell Transplantation","funder_award_id":"P01CA023766","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G2482401937","display_name":"Improving specificity of therapeutic antibodies for cancer.","funder_award_id":"R01CA055349","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7335454695","display_name":"Cancer Pharmacology","funder_award_id":"T32CA062948","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8798105863","display_name":"Weill Cornell/Rockefeller/Sloan Kettering MST Program","funder_award_id":"T32GM007739","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"},{"id":"https://openalex.org/G9000856728","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA008748","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308295","display_name":"Leukemia and Lymphoma Society","ror":"https://ror.org/04m0xav37"},{"id":"https://openalex.org/F4320309468","display_name":"Memorial Sloan-Kettering Cancer Center","ror":"https://ror.org/02yrq0923"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2501746775.pdf","grobid_xml":"https://content.openalex.org/works/W2501746775.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1494334863","https://openalex.org/W1592769050","https://openalex.org/W1600925615","https://openalex.org/W1768515905","https://openalex.org/W1862483413","https://openalex.org/W1929870640","https://openalex.org/W1960710326","https://openalex.org/W1966308488","https://openalex.org/W1973160009","https://openalex.org/W1976515482","https://openalex.org/W1988837817","https://openalex.org/W1991644988","https://openalex.org/W2011118089","https://openalex.org/W2023905569","https://openalex.org/W2028143456","https://openalex.org/W2034924732","https://openalex.org/W2035159305","https://openalex.org/W2048379956","https://openalex.org/W2055401871","https://openalex.org/W2062486240","https://openalex.org/W2068708349","https://openalex.org/W2071775833","https://openalex.org/W2075219903","https://openalex.org/W2105636696","https://openalex.org/W2115311597","https://openalex.org/W2116562208","https://openalex.org/W2119661337","https://openalex.org/W2130122821","https://openalex.org/W2134121541","https://openalex.org/W2134799914","https://openalex.org/W2144242764","https://openalex.org/W2145254159","https://openalex.org/W2148301776","https://openalex.org/W2149420311","https://openalex.org/W2153665789","https://openalex.org/W2154643481","https://openalex.org/W2413052470","https://openalex.org/W4229618832"],"related_works":["https://openalex.org/W2513508089","https://openalex.org/W2293366814","https://openalex.org/W2971902299","https://openalex.org/W1585210355","https://openalex.org/W4313359838","https://openalex.org/W4386019205","https://openalex.org/W1988837817","https://openalex.org/W2106029393","https://openalex.org/W4387935577","https://openalex.org/W2402264487"],"abstract_inverted_index":{"Specific":[0],"immunotherapy":[1],"for":[2,20,26],"acute":[3],"leukemia":[4,130,143,159,206,226],"remains":[5],"a":[6,63,71],"great":[7],"unmet":[8],"need.":[9],"Native":[10],"unmodified":[11],"monoclonal":[12],"antibody":[13,122],"therapies,":[14],"while":[15],"promising,":[16],"are":[17],"inadequately":[18],"effective":[19],"these":[21],"malignancies,":[22],"and":[23,57,164,224],"multiple":[24],"mechanisms":[25,90],"failure":[27],"have":[28],"been":[29],"described.":[30],"Antibody-dependent":[31],"cellular":[32],"cytotoxicity":[33,148],"or":[34,124,127],"phagocytosis":[35],"is":[36,85],"the":[37,52,89,114,136,151,181],"primary":[38],"modality":[39],"of":[40,51,62,82,91,103,113,118,129,138,150,153,184,191,193,199],"mAb-mediated":[41],"cell":[42,119,166,227],"killing":[43],"in":[44,54,58,75,99,180,214],"vivo,":[45],"but":[46],"ultimately":[47],"leads":[48],"to":[49,133,146,186,221],"relapse":[50,93,172],"leukemias,":[53],"model":[55],"systems":[56],"humans.":[59],"By":[60,157],"use":[61],"T-cell":[64],"receptor":[65],"mimic":[66],"mAb":[67,209],"ESKM,":[68],"derived":[69],"against":[70],"WT1":[72],"peptide":[73],"expressed":[74],"complex":[76],"with":[77,111,161,176,208,219],"HLA-A*02:01,":[78],"whose":[79],"only":[80],"mechanism":[81],"therapeutic":[83,97],"action":[84,98],"ADCC,":[86],"we":[87,169],"evaluated":[88],"leukemic":[92,139],"from":[94],"its":[95],"potent":[96],"mouse":[100],"xenograft":[101],"models":[102],"human":[104],"leukemia.":[105],"Leukemia":[106],"escape":[107],"was":[108,144,173],"not":[109],"associated":[110],"loss":[112],"antigenic":[115],"target,":[116],"downregulation":[117],"surface":[120],"HLA,":[121],"pharmacokinetic":[123],"biodistribution":[125],"issues,":[126],"development":[128],"cell-intrinsic":[131],"resistance":[132],"ADCC.":[134],"Interestingly,":[135],"rapidity":[137],"growth":[140,177],"determined":[141],"whether":[142],"able":[145],"evade":[147],"independent":[149],"presence":[152],"sufficient":[154],"effector":[155,185,194],"cells.":[156],"engineering":[158],"cells":[160,195],"upregulated":[162],"p27Kip1":[163],"slower":[165],"cycling":[167],"times,":[168],"show":[170],"that":[171],"inversely":[174],"correlated":[175],"rates":[178],"resulting":[179],"eventual":[182],"inadequacy":[183],"target":[187],"ratio.":[188],"Moreover,":[189],"lack":[190],"migration":[192],"into":[196],"lymphomatous":[197],"pockets":[198],"ALL":[200],"also":[201],"allowed":[202],"local":[203],"escape.":[204],"Successful":[205],"therapy":[207],"might":[210],"therefore":[211],"be":[212],"improved":[213],"similar":[215],"situations":[216],"by":[217],"combination":[218],"measures":[220],"reduce":[222],"burden":[223],"slow":[225],"growth.":[228]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-08-23T00:00:00"}